Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
ACS Appl Mater Interfaces ; 16(25): 31983-31996, 2024 Jun 26.
Article in English | MEDLINE | ID: mdl-38865688

ABSTRACT

Effective osteointegration is of great importance for pedicle screws in spinal fusion surgeries. However, the lack of osteoinductive activity of current screws diminishes their feasibility for osteointegration and fixation, making screw loosening a common complication worldwide. In this study, Ti-6Al-4V pedicle screws with full through-hole design were fabricated via selective laser melting (SLM) 3D printing and then deposited with porous oxide coatings by microarc oxidation (MAO). The porous surface morphology of the oxide coating and the release of bioactive ions could effectively support cell adhesion, migration, vascularization, and osteogenesis in vitro. Furthermore, an in vivo goat model demonstrated the efficacy of modified screws in improving bone maturation and osseointegration, thus providing a promising method for feasible orthopedic internal fixation.


Subject(s)
Ceramics , Goats , Osseointegration , Oxidation-Reduction , Pedicle Screws , Printing, Three-Dimensional , Titanium , Animals , Osseointegration/drug effects , Titanium/chemistry , Titanium/pharmacology , Ceramics/chemistry , Ceramics/pharmacology , Alloys/chemistry , Alloys/pharmacology , Osteogenesis/drug effects , Humans , Porosity , Coated Materials, Biocompatible/chemistry , Coated Materials, Biocompatible/pharmacology , Cell Adhesion/drug effects
2.
Zhonghua Nan Ke Xue ; 23(1): 43-48, 2017 Jan.
Article in Chinese | MEDLINE | ID: mdl-29658236

ABSTRACT

OBJECTIVE: To evaluate the safety, efficacy and tolerability of China-made sildenafil citrate (Jinge) in the treatment of ED. METHODS: We conducted a multi-center, randomized, double-blind and placebo-controlled clinical trial among 222 ED patients in five urological or andrological clinics of China. The patients were randomly assigned to receive sildenafil citrate (SC, n = 111) or placebo (n = 111) for 8 weeks. We obtained and analyzed the demographic and clinical characteristics of the patients, the scores of International Index of Erectile Function (IIEF), the success rate of sexual intercourse, and the incidence of adverse events. RESULTS: No statistically significant differences were found between the patients of the SC and those of the placebo group in the mean age (ï¼»47.2±11.32ï¼½ yr vs ï¼»46.67±13.08ï¼½ yr, P>0.05), psychological etiology (27.93% vs 23.42%, P>0.05), organic etiology (21.62% vs 29.73%, P>0.05) or mixed etiology (50.45% vs 46.85%, P>0.05), nor in height, weight, nationality, or history of smoking, drinking or allergy. Compared with the placebo controls, the SC-treated patients showed significant increases in the excellence rate of effectiveness (29.91% vs 78.90%, P<0.01), success rate of sexual intercourse (29.16% vs 63.87%, P<0.01), and total effectiveness rate (34.58% vs 77.98%, P<0.01). The effectiveness rates on organic, psychogenic and mixed types ED were remarkably higher in the SC group (64.52%, 83.33%, and 82.14%) than in the placebo control (46.15%, 21.21%, and 25.00%) (P<0.01). Mild or temporary adverse events were observed in 32 cases in the SC group as compared with 13 in the placebo control. CONCLUSIONS: China-made sildenafil citrate is an effective, safe and well-tolerated drug for ED of different etiologies in the Chinese population.


Subject(s)
Erectile Dysfunction/drug therapy , Phosphodiesterase 5 Inhibitors/therapeutic use , Sildenafil Citrate/therapeutic use , Aged , China , Coitus , Double-Blind Method , Drug Compounding , Erectile Dysfunction/etiology , Humans , Male , Smoking , Treatment Outcome
3.
Zhonghua Nan Ke Xue ; 12(11): 1044-6, 2006 Nov.
Article in Chinese | MEDLINE | ID: mdl-17146935

ABSTRACT

OBJECTIVE: To study the clinical application and effects of Yuziwan in the treatment of male sterility patient with abnormal protamine. METHODS: The changes of protamine, semen and sex hormones of 30 male sterility patients treated by Yuziwan were observed before and after the treatment. RESULTS: After a 3-month course of treatment, 9 cases were cured, 15 obviously improved and 6 failed to respond. The ratio of histone to protamine was decreased from (1.34 +/- 0.52) before the treatment to (0.72 +/- 0.32) after it, with significant difference (P < 0.01), the semen quality obviously improved (P < 0.05), and the LH and T levels markedly raised (P < 0.01). Yuziwan evidently improved the abnormal protamine, sperm quality and endocrine function of the sterility patients. CONCLUSION: Yuziwan has good curative effect on male sterility.


Subject(s)
Drugs, Chinese Herbal/therapeutic use , Infertility, Male/drug therapy , Phytotherapy , Adult , Histones/metabolism , Humans , Infertility, Male/metabolism , Male , Protamines/metabolism
4.
Zhonghua Nan Ke Xue ; 10(8): 586-8, 2004 Aug.
Article in Chinese | MEDLINE | ID: mdl-15362519

ABSTRACT

OBJECTIVE: To elucidate how chronic prostatitis affects the expression and activity of the plasminogen activator (PA) system and relates to male infertility. METHODS: Twenty-three normal fertile males and 80 chronic prostatitis patients (40 fertile and 40 infertile) were included in this research. SDS polyacrylamide gel electrophoresis and fibrin overlay method were used to estimate the total PA, and tissue PA (tPA), urokinase type PA (uPA) in semen. RESULTS: Total PA, tPA and uPA highly expressed in normal males, but decreased in the semen of the chronic prostatitis patients of both the fertile and infertile groups. However, there was no significant difference in total PA between the fertile and infertile patients. CONCLUSION: Chronic prostatitis reduces the secretory function and PA synthesis and secretion of the prostate, but the decrease of PA alone does not cause infertility. PA may be one of the tools for estimating the function of the prostate.


Subject(s)
Infertility, Male/metabolism , Prostatitis/metabolism , Tissue Plasminogen Activator/biosynthesis , Urokinase-Type Plasminogen Activator/biosynthesis , Adult , Case-Control Studies , Chronic Disease , Humans , Male , Semen/metabolism
5.
Zhonghua Yi Xue Za Zhi ; 84(5): 369-71, 2004 Mar 02.
Article in Chinese | MEDLINE | ID: mdl-15061985

ABSTRACT

OBJECTIVE: To investigate the prevalence of chronic prostatitis (CP) in male infertility patients and its effects on male infertility. METHODS: 534 male patients with complaints of male infertility were interviewed for the history of prostatic disease and underwent digital rectal examination of prostate, analysis of semen and express prostatic secretions (EPS). Bacterial culture of urine was done in 40 randomly selected inflammatory CP patients by pre- and post-message method (pre- and post-massage test, PPMT). RESULTS: 209 out of the 534 patients with male infertility were diagnosed as chronic prostatitis with a prevalence rate of 39.1%, among which 46 with CP type II and IIIA with the prevalence rate of 8.6%, 28 with CP type IIIB (5.2%), and 135 with CP type IV (25.3%) respectively. Positive bacterial culture was found in 10 out of the 40 cases of inflammatory chronic prostatitis (25.0%). The bacterial infection rate was 24.2% (8/33) in the cases of CP type IV. The prevalence rate of liquefaction dysfunction was much higher in the patients of male infertility with CP (22.7%) than in those without CP (14.3%, P < 0.05), however, it had little influence on the quality of semen, pH value, sperm density, and sperm motility. CONCLUSION: Quite common in patients with male infertility, CP prolongs the time of liquefaction, but has no other reverse influence on semen.


Subject(s)
Infertility, Male/etiology , Prostatitis/epidemiology , Adult , China/epidemiology , Chronic Disease , Humans , Male , Prevalence , Prostatitis/complications , Prostatitis/physiopathology , Risk Factors , Semen/cytology , Semen/physiology , Sperm Count , Sperm Motility
6.
Zhonghua Nan Ke Xue ; 10(12): 955-9, 2004 Dec.
Article in Chinese | MEDLINE | ID: mdl-15638033

ABSTRACT

OBJECTIVE: To evaluate the efficacy and safety of vardenafil on men with erectile dysfunction (ED) of various etiologies. METHODS: A total of 88 men with mild to severe erectile dysfunction were enrolled in the randomized, double-blind, placebo-controlled, fixed-dose trial of 12 weeks of treatment with either placebo or 5, 10 and 20 mg of vardenafil. RESULTS: This study indicated that vardenafil dosages of 5, 10 and 20 mg were significantly superior to placebo for the treatment of ED, on the basis of the primary study endpoints of the EF domain score of the IIEF, diary-recorded success rates for penetration and maintenance of erection during the intercourse and the GAQ. Vardenafil was well tolerated. The incidence of adverse events was higher for vardenafil than for placebo. CONCLUSION: Oral vardenafil therapy has a high efficacy and a low incidence of adverse events for ED patients with mixed etiologies.


Subject(s)
Erectile Dysfunction/drug therapy , Imidazoles/therapeutic use , Phosphodiesterase Inhibitors/therapeutic use , Piperazines/therapeutic use , Administration, Oral , Adult , Aged , Double-Blind Method , Humans , Imidazoles/adverse effects , Male , Middle Aged , Phosphodiesterase Inhibitors/adverse effects , Piperazines/adverse effects , Sulfones/adverse effects , Sulfones/therapeutic use , Triazines/adverse effects , Triazines/therapeutic use , Vardenafil Dihydrochloride
SELECTION OF CITATIONS
SEARCH DETAIL
...